News

Erin Calipari, an assistant professor in the Department of Pharmacology at Vanderbilt University, recently visited the University of Kentucky to give a talk about her work in addiction research.

While it isn’t typically the role of emergency medicine clinicians to identify chronic diseases, Dr. J. Daniel Moore, assistant professor of emergency medicine in the University of Kentucky College of Medicine, knew it had to become their job.

Working with the UK Department of Obstetrics and Gynecology, a group led by Kevin Pearson in UK's Department of Pharmacology and Nutritional Sciences was able to identify a potential cellular mechanism that connects a mother's smoking while pregnant with an increased risk of offspring obesity later in life.

On this week's episode of "Behind the Blue" hear about the development of "Find Help Now KY" from Terry Bunn, an associate professor in the University of Kentucky College of Public Health and director of the Kentucky Injury Prevention and Research Center.

Svetla Slavova, Ph.D., associate professor of biostatistics in the UK College of Public Health's Kentucky Injury Prevention and Research Center, will lead work that includes collaboration with the Kentucky All Schedule Prescription Electronic Reporting (KASPER) system, the Kentucky Office of Vital Statistics and the Office of the Chief Medical Examiner.

A multidisciplinary team of UK physicians and researchers will collaborate with additional specialists to develop diagnosis-specific educational materials to address opioid pain management options post-discharge, pain management alternatives to opioids and information on safe opioid use, storage and disposal.

PATHways and Beyond Birth program participant Bethany shares her recovery story to help others and thank those who helped her.

On this episode of "Behind the Blue," Sharon Walsh, director of the University of Kentucky’s Center on Drug and Alcohol Research (CDAR) and a distinguished professor in the UK College of Medicine, discusses the challenge Kentucky faces in battling the opioid epidemic.

Researchers at the University of Kentucky College of Medicine have discovered that targeting a specific signaling pathway could potentially provide a new therapeutic avenue for treating Fetal Alcohol Syndrome, the most severe fetal alcohol spectrum disorder.

Experts from the University of Kentucky on Thursday provided education, insight and information about the opioid epidemic to the UK Board of Trustees, campus leaders and community members.